The autoinjectors market is projected to be worth around USD 1.5 Billion by 2030

Roots Analysis has announced the addition of "Global Autoinjectors Market (3rd Edition), 2020-2030" report to its list of offerings.
ARDSLEY, N.Y. - March 18, 2020 - PRLog -- In addition to enabling patients to self-medicate, these devices are designed to ensure safety during the dosing process and promote compliance to prescribed therapeutic regimens. Moreover, the adoption of autoinjectors, and other self-injection products, has enabled significant cost savings for end users by eliminating the need to visit hospitals / out-patient clinics for dosing.

To order this 600+ page report, which features 360+ figures and 350+ tables, please visit this link (

Key Market Insights

Close to 80 autoinjector devices are presently available / under development
About 80% of these devices are disposable and intended for single use only, while the others are designed to be reusable. Further, it is interesting to note that more than 40% of such devices have provisions that allow variable dose administration.

Nearly 120 autoinjector combination products are either already available or under investigation
Of these, ~90 autoinjectors are approved for use in the treatment of indications, such as rheumatoid arthritis and / or psoriasis (including other forms of arthritis), multiple sclerosis, anaphylaxis and organophosphate poisoning.

Over 120 drugs were identified as likely candidate to be made available in combination with autoinjectors
The report features insights on the likelihood of over 250+ marketed drugs and pipeline candidates, being developed in combination with autoinjectors. The analysis takes into consideration several parameters, such as current phase of development of the drug candidate, target indication, dosing frequency, type of drug molecule, annual sales (for marketed drugs) and available delivery systems (for marketed drugs).

The report features inputs from eminent industry stakeholders, according to whom autoinjectors address several limitations of conventional parenteral drug delivery process, by preventing accidental needle-stick injuries, dosing errors and are preferred even by patients with trypanophobia. The report includes detailed transcripts of discussions held with the following experts

For additional details, please visit

or email (

You may also be interested in the following titles:

• Prefilled Syringes Market (5th Edition), 2019-2030
• Novel Vaccine Delivery Devices Market, 2019-2030
• Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030

Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Posted By:*** Email Verified
Location:Ardsley - New York - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse

Most Viewed
Top Monthly News
PTC News

Mar 18, 2020 News

Like PRLog?
Click to Share